Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

How has avalglucosidase alfa impacted the treatment paradigm for both infantile-onset and late-onset Pompe disease in your experience?

Pompe Care Podcast Series 3

What factors influence your decision to switch a patient from alglucosidase alfa to avalglucosidase alfa?

Structured Monitoring for Early Detection of Fabry Progression

Renal Outcomes After Switching to Agalsidase Beta: A Single-Center Analysis

Dupilumab for Patients with AFRS

The Many Faces of Limb-Girdle Weakness

Differentail Diagnosis for Unspecific Limb - Girdle Muscular Dystrophy (LGMD)/ Dr. Alanood Alsolaihim

When the Heart, Kidneys, and Nerves Intersect

Differentail Diagnosis for Patient with Unexplained Neuropathic Pain, Unknown LVH, or Dialysis Requirements. Dr. Khalid Naji

When Weakness Tells a Bigger Story

It's Not Just A Wakness/ Dr. Ahmed Bamaga

The Enlarged Spleen Mystery

Patient With Hepatosplenomegaly and Multiple Splenic lesions/Dr. Ahmed Al Shomer

When Hematological Signs Lead the Diagnosis

A Case of Unexplained Growth Delay with Hematological Manifestation/Dr. Mahmud Al Mutadares

The Pathophysiology of Prurigo Nodularis